Chemours Company (The) ($CC) Stock Forecast: Down 5.2% Today

What is Chemours Company (The)?

Chemours (CC) is a chemical company recognized for its expertise in titanium technologies, fluoroproducts, and chemical solutions across sectors such as mining, automotive, and construction.

Why is Chemours Company (The) going down?

CC stock is down 5.2% on May 21, 2026 16:35

• Chemours (CC) stock saw a significant decline of 8.4% today.
• A Q1 2026 net loss of US$29 million was reported by the company, possibly contributing to the negative market reaction.
• Despite unveiling new guidance for a profitable trajectory in 2026, concerns regarding PFAS litigation and the necessity for successful execution of the guidance appear to have overshadowed the positive outlook.
• Ongoing legal disputes with the North Carolina Attorney General concerning environmental issues and the uncertainty surrounding the lawsuit's resolution may also be impacting investor confidence in Chemours.

CC Price Chart

CC Technical Analysis

CC News

Chemours makes case to top NC court for tossing AG Jackson’s lawsuit

Chemours and DuPont are petitioning the North Carolina Supreme Court to dismiss Attorney General Jeff Jackson's environmental contamination lawsuit, arguing it's a duplicative attempt to extract more money after a prior settlement with the NC Department of Environmental Quality. The companies contend that Jackson lacks the authority to pursue a second lawsuit for the same alleged harms already addressed by a binding consent order. The Supreme Court will hear oral arguments on September 15, with justices divided on the matter and significant debate over the Attorney General's common-law authority versus regulatory agency roles.

https://www.carolinajournal.com/chemours-makes-case-to-top-nc-court-for-tossing-ag-jacksons-lawsuit/

Chemours (CC) Is Down 8.4% After Issuing 2026 Profit Guidance Amid Q1 Net Loss

Chemours (CC) recently reported a Q1 2026 net loss of US$29 million but issued new guidance projecting full-year 2026 net income between US$165 million and US$225 million. This guidance provides a clearer path to profitability for the company, although persistent concerns about PFAS litigation and the need for strong execution on this new guidance remain key challenges. Despite the improved earnings outlook, current analyst models project a 29% downside to Chemours' fair value.

https://simplywall.st/stocks/us/materials/nyse-cc/chemours/news/chemours-cc-is-down-84-after-issuing-2026-profit-guidance-am

Trending Today

Jetblue Airways Corporation ($JBLU) Stock Forecast: Up 5.6% Today

BlackLine, Inc. ($BL) Stock Forecast: Down 5.7% Today

Eastman Chemical Company ($EMN) Stock Forecast: Up 5.0% Today

Groupon Inc. ($GRPN) Stock Forecast: Up 5.4% Today

Parker-Hannifin Corporation ($PH) Stock Forecast: Up 1.2% Today

Walmart Inc. ($WMT) Stock Forecast: Down 7.3% Today

Alaska Air Group Inc. ($ALK) Stock Forecast: Up 1.8% Today

Robert Half Inc. ($RHI) Stock Forecast: Up 5.0% Today

Grab Holdings Limited ($GRAB) Stock Forecast: Up 1.7% Today

Reddit Inc ($RDDT) Stock Forecast: Up 5.0% Today

Chemours Company (The) Price History

10.03.2026 - CC Stock was up 5.4%

• Chemours (CC) experienced a strong bullish movement today due to an increased target price and maintained Buy rating by a leading financial institution. This positive outlook reflects confidence in the company's growth potential.
• The high-performance fluoropolymers (HPF) market is projected to grow, potentially benefiting Chemours given its presence in industrial chemicals, including components for aerospace and automotive industries.
• Despite the positive forecast and price target increase, Chemours reported a negative net margin and a year-over-year revenue decline, suggesting possible challenges ahead despite the bullish market movement.
• Ongoing discussions by the EU chemicals agency regarding PFAS chemicals could have implications for Chemours in the future, underscoring regulatory risks in the industry.

07.04.2026 - CC Stock was down 5.2%

• Chemours (CC) recorded a Q1 loss of US$29 million, raising concerns about its profitability and influencing the bearish market trend.
• Despite displaying some positive operational advancements, the stock faced a 13% decline due to the market's negative response to adjusted earnings guidance and heightened financial commitments.
• The company's declaration of a quarterly cash dividend potentially offered some stability, but the focus on margins, revenue growth, and financial pressures contributed to the prevailing bearish outlook.
• Observers are particularly attentive to Chemours' pricing strategies, operational efficiencies, and ability to navigate geopolitical challenges as they evaluate its future trajectory and market sentiment.

30.03.2026 - CC Stock was up 5.0%

• The significant stock price appreciation of Chemours (CC) can be attributed to multiple factors:
• Despite differing views on its valuation, the stock has experienced a surge in price, indicating investor confidence in its future.
• Investments by Vanguard Capital Management and Vanguard Portfolio Management have further bolstered faith in the company's growth.
• The recent peak in stock price reflects positive momentum and investor attraction towards Chemours.
• Concerns raised by Cumberland County about PFAS contamination pose potential risks for Chemours, potentially affecting its future stock performance.

16.03.2026 - CC Stock was up 5.1%

• Chemours (CC) reached a new 52-week high of $23.20, trading with high volume and significantly above its moving averages, reflecting robust investor interest and positive market sentiment.
• The increase in Chemours' stock price can be linked to the company's recent strong financial performance, surpassing EPS expectations, despite having certain mixed fundamentals like negative net margin and P/E ratio.
• The update about Southeast Ohio water authorities securing funds for PFAS treatment upgrades may have had a positive impact on Chemours, given the company's involvement in producing chemicals and solutions relevant for water treatment processes.
• Despite being labeled as overvalued by some analysts, there appears to be a positive market outlook on Chemours' future prospects, with institutions like UBS raising their price target and reaffirming a "Buy" rating.

21.04.2026 - CC Stock was down 5.2%

• Chemours (CC) stock saw a significant decline of 8.4% today.
• A Q1 2026 net loss of US$29 million was reported by the company, possibly contributing to the negative market reaction.
• Despite unveiling new guidance for a profitable trajectory in 2026, concerns regarding PFAS litigation and the necessity for successful execution of the guidance appear to have overshadowed the positive outlook.
• Ongoing legal disputes with the North Carolina Attorney General concerning environmental issues and the uncertainty surrounding the lawsuit's resolution may also be impacting investor confidence in Chemours.

09.03.2026 - CC Stock was up 5.6%

• CC reached a 52-week high at $22.56, marking a 139% increase in the past year, potentially attracting positivity from investors.
• Mizuho raised CC's price target to $25 from $21, upholding an "Outperform" rating, potentially enhancing investor confidence and influencing the bullish trend.
• Despite the lawsuit and regulatory challenges, CC's optimistic earnings forecast for 2026 and expected improvements in titanium dioxide EBITDA margins may have outweighed these issues, propelling the stock.
• The options chain analysis, detailing call and put options expiring in May 2026, possibly signified a bullish outlook among traders, adding momentum to CC's stock.

19.04.2026 - CC Stock was down 7.3%

• Chemours reported a Q1 net loss but issued new guidance projecting a path to profitability for the full year, leading to investor concerns and contributing to the bearish movement.
• Despite receiving awards for energy efficiency and sustainable manufacturing initiatives, persistent concerns about PFAS litigation and the need for strong execution on new guidance continue to weigh on investor sentiment.
• The company's CFO discussed cost reduction strategies and forecasted adjusted EBITDA, but uncertainties around PFAS-related liabilities and tariffs impact on business operations may have added to the downward pressure on the stock.
• The industry study highlighting a path to cut automotive refrigerant emissions in Europe could have a positive long-term impact on Chemours' sustainability efforts, but the immediate market reaction seems to have been influenced more by the near-term financial outlook and litigation concerns.

15.04.2026 - CC Stock was down 5.2%

• The bearish movement in Chemours Corporation's stock (CC) today could be attributed to several factors:
• Despite receiving recognition for its energy efficiency initiatives and sustainable manufacturing practices, investors may have been looking for more immediate financial gains rather than long-term sustainability efforts.
• Discussions of cost reductions and adjusted EBITDA forecasts might have raised concerns about potential challenges in achieving these targets, leading to a lack of confidence among investors.
• The actions to cut automotive refrigerant emissions in Europe, while positive for the environment, may have raised questions about the company's future revenue streams if regulatory changes impact its products in the automotive sector.
• The information about the number of shareholders could indicate a lack of significant new investors or institutional interest in the company, potentially signaling a lack of market confidence in CC's growth prospects.

24.03.2026 - CC Stock was up 5.1%

• The bullish movement in CC stock today could be attributed to the positive growth outlook for the global fluoropolymer films market, driven by demand in high-performance industries like electronics and automotive.
• Earth Day petitions urging Chemours to protect the Okefenokee Swamp may have also fueled investor optimism, highlighting the company's dedication to environmental responsibility and sustainability.
• The forthcoming Q1 financial results announcement on May 5 and the subsequent public webcast on May 6 may be creating anticipation and confidence among investors, contributing to the bullish market activity in CC stock.

06.04.2026 - CC Stock was down 16.0%

• Today, Chemours experienced a decline in its stock price, possibly due to the company's failure to meet revenue expectations in Q1, reporting $1.38 billion instead of the anticipated $1.40 billion.
• While announcing a new dividend and achieving a 52-week high were positive developments, the slight revenue miss may have raised uncertainties among investors about the company's future growth.
• The use of AI models indicating increased downside risk at current levels might have also influenced bearish sentiment, leading some investors to cash in profits or adjust their positions cautiously.
• The market's response appears to combine profit-taking following recent strong performance and some ambiguity surrounding Chemours' revenue outlook in the short term.

05.04.2026 - CC Stock was up 5.5%

• CC stock hit a new 52-week high of $27.53, marking a significant 130% year-to-date increase, driven by strong investor confidence and strategic growth measures.
• The successful $700 million debt issuance to retire existing notes and positive analyst projections regarding enhanced profitability and higher titanium dioxide EBITDA margins have further propelled the optimistic sentiment.
• Despite concerns raised about potential overvaluation, positive market sentiment, approval of equity plans by shareholders, and the appointment of an independent auditor have all played a role in the stock's upward trend.
• Strategic decisions, such as the endorsement of the 2026 Equity and Incentive Plan and favorable analyst reviews, are likely factors boosting investor confidence and contributing to the positive momentum in CC stock.

11.04.2026 - CC Stock was up 5.0%

• The positive sentiment surrounding CC stock's uptrend might be linked to the completion of a Euro-denominated term loan repricing, hinting at potential cost savings for the company.
• Notable insider stock grants were awarded to directors Courtney Mather, Mary B. Cranston, and Erin N. Kane, potentially boosting investor confidence in the company's growth trajectory.
• The equity awards given to directors in a non-cash form indicate alignment with shareholders' interests, which could enhance investor trust in the stock.
• In summary, a mix of favorable financial updates and insider activities likely fueled the bullish movement of CC stock during the day.